ARTICLE | Company News
Otsuka Pharmaceutical sales and marketing update
May 23, 2016 7:00 AM UTC
Otsuka’s Avanir Pharmaceuticals Inc. subsidiary launched Onzetra Xsail sumatriptan nasal powder in the U.S. to treat acute migraine with or without aura in adults. The wholesale acquisition cost (WA...